Investigation of the Effect of Meclofenamic Acid on the Proteome of LNCaP Cells Reveals Changes in Alternative Polyadenylation and Splicing Machinery

Meclofenamic acid, a non-steroidal anti-inflammatory drug, with anti-tumor effects in various types of cancers, was used to investigate its effects on LNCaP cells, a prostate cancer cell line, at the proteome level.
[Medical Oncology]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News